Aesthetic medicine products. Galderma CEO ‘doubles down on science’ ahead of potential IPO
THE WHAT? Flemming Ornskov, Galderma CEO, has stated he is ‘doubling down on science’ ahead of the company’s preparation for an IPO. THE DETAILS Ornskov is said to be accelerating research spending and adding dermatologists and medical specialists to the roster in a bid to navigate the skincare business on a new course. Ornskov is looking to …